Literature DB >> 32194648

Neurochemical Correlates of Executive Function in Children with Attention-Deficit/Hyperactivity Disorder.

Tasmia Hai1, Hanna Duffy1, Jean-Francois Lemay2, Rose Swansburg3, Emma A Climie1, Frank P MacMaster3.   

Abstract

OBJECTIVES: Attention-Deficit/Hyperactivity Disorder (ADHD) is a prevalent neurodevelopmental disorder with no known biomarkers. The objectives of this study were 1) to investigate spectroscopic biomarkers in the right prefrontal cortex (R-PFC) and left striatum; 2) to evaluate Executive Function (EF) performance; and, 3) to examine the clinical relevance of glutamate in EF tasks.
METHODS: A total of 21 children with ADHD (M = 10.41 years, SD = 1.41) and 15 controls without ADHD (M = 9.90 years, SD = 1.54 years) were enrolled. Short echo proton magnetic resonance spectroscopy (1H-MRS; TE = 30ms) was used to study the changes in the R-PFC and left striatum. Both groups completed an EF assessment battery, including working memory, inhibition, cognitive flexibility and verbal fluency tasks.
RESULTS: In the R-PFC, independent t-tests found decreased concentration of glutamate (p = 0.009), NAA (p = 0.029) and choline (p = 0.016) in ADHD participants compared to controls. No significant differences were seen in the left striatum. Multivariate analysis of variance did not indicate overall EF challenges in the ADHD sample (p < .05). Positive correlations with glutamate concentration and EF performance in the control group were observed, however, no such correlations were reported in the ADHD group.
CONCLUSIONS: The results indicated a subgroup of children with ADHD who presented with hypo-glutamatergic signalling in the R-PFC. Additionally, findings suggested a decoupling effect of glutamate in EF related tasks in children with ADHD compared to controls. Thus, glutamate concentration may be a possible ADHD biomarker and novel treatments target.
Copyright © 2020 Canadian Academy of Child and Adolescent Psychiatry.

Entities:  

Keywords:  attention-deficit/hyperactivity disorder; biomarkers; executive function; glutamate; magnetic resonance spectroscopy

Year:  2020        PMID: 32194648      PMCID: PMC7065568     

Source DB:  PubMed          Journal:  J Can Acad Child Adolesc Psychiatry        ISSN: 1719-8429


  43 in total

1.  Proton magnetic resonance spectroscopy and cognitive function in pediatric attention-deficit/hyperactive disorder.

Authors:  S J Sparkes; F P MacMaster; N C Carrey
Journal:  Brain Cogn       Date:  2004-03       Impact factor: 2.310

Review 2.  Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review.

Authors:  Erik G Willcutt; Alysa E Doyle; Joel T Nigg; Stephen V Faraone; Bruce F Pennington
Journal:  Biol Psychiatry       Date:  2005-06-01       Impact factor: 13.382

Review 3.  Glutamatergic dysregulation in pediatric psychiatric disorders: a systematic review of the magnetic resonance spectroscopy literature.

Authors:  Andrea E Spencer; Mai Uchida; Tara Kenworthy; Christopher J Keary; Joseph Biederman
Journal:  J Clin Psychiatry       Date:  2014-11       Impact factor: 4.384

4.  Attention-deficit disorder in adults with or without hyperactivity: where is the difference? A study in humans using short echo (1)H-magnetic resonance spectroscopy.

Authors:  B Hesslinger; T Thiel; L Tebartz van Elst; J Hennig; D Ebert
Journal:  Neurosci Lett       Date:  2001-05-18       Impact factor: 3.046

Review 5.  The role of glutamate receptors in attention-deficit/hyperactivity disorder: From physiology to disease.

Authors:  Xin Huang; Min Wang; Qi Zhang; Xinzhen Chen; Jing Wu
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2019-04-05       Impact factor: 3.568

6.  Metabolite changes resulting from treatment in children with ADHD: a 1H-MRS study.

Authors:  Normand Carrey; Frank P MacMaster; Joshua Fogel; Sandra Sparkes; Dan Waschbusch; Sara Sullivan; Mathias Schmidt
Journal:  Clin Neuropharmacol       Date:  2003 Jul-Aug       Impact factor: 1.592

Review 7.  Recent advances in structural and functional brain imaging studies of attention-deficit/hyperactivity disorder.

Authors:  A M Clare Kelly; Daniel S Margulies; F Xavier Castellanos
Journal:  Curr Psychiatry Rep       Date:  2007-10       Impact factor: 5.285

8.  Executive functions: performance-based measures and the behavior rating inventory of executive function (BRIEF) in adolescents with attention deficit/hyperactivity disorder (ADHD).

Authors:  Maggie E Toplak; Stefania M Bucciarelli; Umesh Jain; Rosemary Tannock
Journal:  Child Neuropsychol       Date:  2009-01       Impact factor: 2.500

9.  Striatal creatine and glutamate/glutamine in attention-deficit/hyperactivity disorder.

Authors:  Normand J Carrey; Frank P MacMaster; Laura Gaudet; Matthias H Schmidt
Journal:  J Child Adolesc Psychopharmacol       Date:  2007-02       Impact factor: 2.576

10.  Cerebellar neurometabolite abnormalities in pediatric attention/deficit hyperactivity disorder: a proton MR spectroscopic study.

Authors:  Juan Carlos Soliva; Ana Moreno; Jordi Fauquet; Anna Bielsa; Susanna Carmona; Juan Domingo Gispert; Mariana Rovira; Antoni Bulbena; Oscar Vilarroya
Journal:  Neurosci Lett       Date:  2009-12-29       Impact factor: 3.046

View more
  1 in total

1.  Neuroimaging of Supraventricular Frontal White Matter in Children with Familial Attention-Deficit Hyperactivity Disorder and Attention-Deficit Hyperactivity Disorder Due to Prenatal Alcohol Exposure.

Authors:  Jeffry R Alger; Joseph O'Neill; Mary J O'Connor; Guldamla Kalender; Ronald Ly; Andrea Ng; Andrea Dillon; Katherine L Narr; Sandra K Loo; Jennifer G Levitt
Journal:  Neurotox Res       Date:  2021-03-22       Impact factor: 3.978

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.